[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Mycoplasma Diagnostics Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: M55037A41F0BEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.

This report contains market size and forecasts of Mycoplasma Diagnostics in Global, including the following market information:

Global Mycoplasma Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mycoplasma Diagnostics market was valued at 679.7 million in 2021 and is projected to reach US$ 1005.4 million by 2028, at a CAGR of 5.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Kits & Reagents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mycoplasma Diagnostics include Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics and Tecan Trading (Tecan Group), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mycoplasma Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mycoplasma Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mycoplasma Diagnostics Market Segment Percentages, by Type, 2021 (%)
  • Kits & Reagents
  • Instruments
  • Software & Services
Global Mycoplasma Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mycoplasma Diagnostics Market Segment Percentages, by Application, 2021 (%)
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Others
Global Mycoplasma Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mycoplasma Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mycoplasma Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mycoplasma Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Agilent Technologies
  • Thermo Fisher Scientific
  • PromoCell
  • Charles River Laboratories International
  • Merck KGaA
  • Lonza Group
  • Takara Bio (Takara Holding Company.)
  • Savyon Diagnostics
  • Tecan Trading (Tecan Group)
  • Sartorius Stedim BioOutsource
  • American Type Culture Collection (ATCC)
  • F Hoffmann-La Roche
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mycoplasma Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mycoplasma Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MYCOPLASMA DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Mycoplasma Diagnostics Market Size: 2021 VS 2028
2.2 Global Mycoplasma Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mycoplasma Diagnostics Players in Global Market
3.2 Top Global Mycoplasma Diagnostics Companies Ranked by Revenue
3.3 Global Mycoplasma Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Mycoplasma Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mycoplasma Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mycoplasma Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Mycoplasma Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mycoplasma Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mycoplasma Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Kits & Reagents
  4.1.3 Instruments
  4.1.4 Software & Services
4.2 By Type - Global Mycoplasma Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Mycoplasma Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Mycoplasma Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Mycoplasma Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mycoplasma Diagnostics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Laboratories
  5.1.4 Clinics
  5.1.5 Others
5.2 By Application - Global Mycoplasma Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Mycoplasma Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Mycoplasma Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Mycoplasma Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mycoplasma Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Mycoplasma Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Mycoplasma Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Mycoplasma Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Mycoplasma Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mycoplasma Diagnostics Revenue, 2017-2028
  6.3.2 US Mycoplasma Diagnostics Market Size, 2017-2028
  6.3.3 Canada Mycoplasma Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Mycoplasma Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mycoplasma Diagnostics Revenue, 2017-2028
  6.4.2 Germany Mycoplasma Diagnostics Market Size, 2017-2028
  6.4.3 France Mycoplasma Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Mycoplasma Diagnostics Market Size, 2017-2028
  6.4.5 Italy Mycoplasma Diagnostics Market Size, 2017-2028
  6.4.6 Russia Mycoplasma Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Mycoplasma Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Mycoplasma Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mycoplasma Diagnostics Revenue, 2017-2028
  6.5.2 China Mycoplasma Diagnostics Market Size, 2017-2028
  6.5.3 Japan Mycoplasma Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Mycoplasma Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Mycoplasma Diagnostics Market Size, 2017-2028
  6.5.6 India Mycoplasma Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mycoplasma Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Mycoplasma Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Mycoplasma Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mycoplasma Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Mycoplasma Diagnostics Market Size, 2017-2028
  6.7.3 Israel Mycoplasma Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Mycoplasma Diagnostics Market Size, 2017-2028
  6.7.5 UAE Mycoplasma Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Agilent Technologies
  7.1.1 Agilent Technologies Corporate Summary
  7.1.2 Agilent Technologies Business Overview
  7.1.3 Agilent Technologies Mycoplasma Diagnostics Major Product Offerings
  7.1.4 Agilent Technologies Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Agilent Technologies Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific Mycoplasma Diagnostics Major Product Offerings
  7.2.4 Thermo Fisher Scientific Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 PromoCell
  7.3.1 PromoCell Corporate Summary
  7.3.2 PromoCell Business Overview
  7.3.3 PromoCell Mycoplasma Diagnostics Major Product Offerings
  7.3.4 PromoCell Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 PromoCell Key News
7.4 Charles River Laboratories International
  7.4.1 Charles River Laboratories International Corporate Summary
  7.4.2 Charles River Laboratories International Business Overview
  7.4.3 Charles River Laboratories International Mycoplasma Diagnostics Major Product Offerings
  7.4.4 Charles River Laboratories International Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Charles River Laboratories International Key News
7.5 Merck KGaA
  7.5.1 Merck KGaA Corporate Summary
  7.5.2 Merck KGaA Business Overview
  7.5.3 Merck KGaA Mycoplasma Diagnostics Major Product Offerings
  7.5.4 Merck KGaA Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Merck KGaA Key News
7.6 Lonza Group
  7.6.1 Lonza Group Corporate Summary
  7.6.2 Lonza Group Business Overview
  7.6.3 Lonza Group Mycoplasma Diagnostics Major Product Offerings
  7.6.4 Lonza Group Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Lonza Group Key News
7.7 Takara Bio (Takara Holding Company.)
  7.7.1 Takara Bio (Takara Holding Company.) Corporate Summary
  7.7.2 Takara Bio (Takara Holding Company.) Business Overview
  7.7.3 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Major Product Offerings
  7.7.4 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Takara Bio (Takara Holding Company.) Key News
7.8 Savyon Diagnostics
  7.8.1 Savyon Diagnostics Corporate Summary
  7.8.2 Savyon Diagnostics Business Overview
  7.8.3 Savyon Diagnostics Mycoplasma Diagnostics Major Product Offerings
  7.8.4 Savyon Diagnostics Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Savyon Diagnostics Key News
7.9 Tecan Trading (Tecan Group)
  7.9.1 Tecan Trading (Tecan Group) Corporate Summary
  7.9.2 Tecan Trading (Tecan Group) Business Overview
  7.9.3 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Major Product Offerings
  7.9.4 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 Tecan Trading (Tecan Group) Key News
7.10 Sartorius Stedim BioOutsource
  7.10.1 Sartorius Stedim BioOutsource Corporate Summary
  7.10.2 Sartorius Stedim BioOutsource Business Overview
  7.10.3 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Major Product Offerings
  7.10.4 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 Sartorius Stedim BioOutsource Key News
7.11 American Type Culture Collection (ATCC)
  7.11.1 American Type Culture Collection (ATCC) Corporate Summary
  7.11.2 American Type Culture Collection (ATCC) Business Overview
  7.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Major Product Offerings
  7.11.4 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.11.5 American Type Culture Collection (ATCC) Key News
7.12 F Hoffmann-La Roche
  7.12.1 F Hoffmann-La Roche Corporate Summary
  7.12.2 F Hoffmann-La Roche Business Overview
  7.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Major Product Offerings
  7.12.4 F Hoffmann-La Roche Mycoplasma Diagnostics Revenue in Global Market (2017-2022)
  7.12.5 F Hoffmann-La Roche Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Mycoplasma Diagnostics Market Opportunities & Trends in Global Market
Table 2. Mycoplasma Diagnostics Market Drivers in Global Market
Table 3. Mycoplasma Diagnostics Market Restraints in Global Market
Table 4. Key Players of Mycoplasma Diagnostics in Global Market
Table 5. Top Mycoplasma Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mycoplasma Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mycoplasma Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mycoplasma Diagnostics Product Type
Table 9. List of Global Tier 1 Mycoplasma Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mycoplasma Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mycoplasma Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mycoplasma Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mycoplasma Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mycoplasma Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mycoplasma Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mycoplasma Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mycoplasma Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mycoplasma Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mycoplasma Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mycoplasma Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mycoplasma Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mycoplasma Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mycoplasma Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mycoplasma Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Agilent Technologies Corporate Summary
Table 31. Agilent Technologies Mycoplasma Diagnostics Product Offerings
Table 32. Agilent Technologies Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific Mycoplasma Diagnostics Product Offerings
Table 35. Thermo Fisher Scientific Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. PromoCell Corporate Summary
Table 37. PromoCell Mycoplasma Diagnostics Product Offerings
Table 38. PromoCell Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Charles River Laboratories International Corporate Summary
Table 40. Charles River Laboratories International Mycoplasma Diagnostics Product Offerings
Table 41. Charles River Laboratories International Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Merck KGaA Corporate Summary
Table 43. Merck KGaA Mycoplasma Diagnostics Product Offerings
Table 44. Merck KGaA Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Lonza Group Corporate Summary
Table 46. Lonza Group Mycoplasma Diagnostics Product Offerings
Table 47. Lonza Group Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Takara Bio (Takara Holding Company.) Corporate Summary
Table 49. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Product Offerings
Table 50. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Savyon Diagnostics Corporate Summary
Table 52. Savyon Diagnostics Mycoplasma Diagnostics Product Offerings
Table 53. Savyon Diagnostics Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Tecan Trading (Tecan Group) Corporate Summary
Table 55. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Product Offerings
Table 56. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Sartorius Stedim BioOutsource Corporate Summary
Table 58. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Product Offerings
Table 59. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. American Type Culture Collection (ATCC) Corporate Summary
Table 61. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product Offerings
Table 62. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. F Hoffmann-La Roche Corporate Summary
Table 64. F Hoffmann-La Roche Mycoplasma Diagnostics Product Offerings
Table 65. F Hoffmann-La Roche Mycoplasma Diagnostics Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Mycoplasma Diagnostics Segment by Type in 2021
Figure 2. Mycoplasma Diagnostics Segment by Application in 2021
Figure 3. Global Mycoplasma Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mycoplasma Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mycoplasma Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mycoplasma Diagnostics Revenue in 2021
Figure 8. By Type - Global Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mycoplasma Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mycoplasma Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Agilent Technologies Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. PromoCell Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Charles River Laboratories International Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck KGaA Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lonza Group Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Savyon Diagnostics Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. F Hoffmann-La Roche Mycoplasma Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications